LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Medical Questions » Alpha Lipoic Acid Useful for Neuropathy?

 - UBBFriend: Email this page to someone!    
Author Topic: Alpha Lipoic Acid Useful for Neuropathy?
NorthernLyme1
Member
Member # 8992

Icon 1 posted      Profile for NorthernLyme1     Send New Private Message       Edit/Delete Post   Reply With Quote 
Here is some interesting info on ALA and its application to various distal symmetric polyneuropathic presentations such as stabbing, burning, tingling, prickling and numbness of the feet as published in a German-based study. See abstract below.

Has anyone had any success using ALA against these awful symptoms that are widespread amongst those with Lyme?

http://www.juvenon.com/jhj/vol6no04.htm?campaign=emailv6no4

Twelve German, Russian, American and Israeli researchers recently conducted a multicenter, double-blind, placebo-controlled clinical trial to examine the effects of alpha lipoic acid (ALA) on neuropathic symptoms in type II diabetic patients.

The summary of their methods, findings and conclusions can be found in the November, 2006, issue of Diabetes Care.

During the trial, 181 patients in Russia and Israel received daily oral doses of ALA or a placebo for five weeks. The primary outcome measure was the change from baseline of the Total Symptom Score (TSS), including measurements of stabbing pain, burning pain, paresthesia (tingling or pricking), and numbness of the feet.

In addition to demonstrating an improvement in TSS with ALA doses of 600 mg to 1800 mg per day, the research also identified 600 mg as the dose with the optimum risk-to-benefit ratio. The authors make note of a low incidence of side effects.

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R.

FRCPE, Deutsche Diabetes-Klinik, Deutsches Diabetes-Zentrum, Leibniz-Institut an der Heinrich-Heine-Universitat, Auf'm Hennekamp 65, 40225 Dusseldorf, Germany. [email protected]

Diabetes Care 29:2365-2370, 2006
DOI: 10.2337/dc06-1216
� 2006 by the American Diabetes Association


OBJECTIVE:

The aim of this trial was to evaluate the effects of alpha-lipoic acid [ALA] on positive sensory symptoms and neuropathic deficits in diabetic patients with distal symmetric polyneuropathy [DSP].

RESEARCH DESIGN AND METHODS:

In this multicenter, randomized, double-blind, placebo-controlled trial, 181 diabetic patients in Russia and Israel received once-daily oral doses of 600 mg [n = 45] [ALA600], 1,200 mg [n = 47] [ALA1200], and 1,800 mg [ALA1800] of ALA [n = 46] or placebo [n = 43] for 5 weeks after a 1-week placebo run-in period.

The primary outcome measure was the change from baseline of the Total Symptom Score [TSS], including stabbing pain, burning pain, paresthesia, and asleep numbness of the feet. Secondary end points included individual symptoms of TSS, Neuropathy Symptoms and Change [NSC] score, Neuropathy Impairment Score (NIS), and patients' global assessment of efficacy.

RESULTS:

Mean TSS did not differ significantly at baseline among the treatment groups and on average decreased by 4.9 points [51%] in ALA600, 4.5 [48%] in ALA1200, and 4.7 [52%] in ALA1800 compared with 2.9 points [32%] in the placebo group [all P < 0.05 vs. placebo]. The corresponding response rates [>/=50% reduction in TSS] were 62, 50, 56, and 26%, respectively.

Significant improvements favoring all three ALA groups were also noted for stabbing and burning pain, the NSC score, and the patients' global assessment of efficacy. The NIS was numerically reduced. Safety analysis showed a dose-dependent increase in nausea, vomiting, and vertigo.

CONCLUSIONS:

Oral treatment with ALA for 5 weeks improved neuropathic symptoms and deficits in patients with DSP. An oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.

PMID: 17065669 [PubMed - indexed for MEDLINE]

Posts: 59 | From Canada | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
TerryK
Frequent Contributor (5K+ posts)
Member # 8552

Icon 1 posted      Profile for TerryK     Send New Private Message       Edit/Delete Post   Reply With Quote 
I have been taking alpha lipoic acid 100 mg 2X per day for years for blood sugar but didn't notice any improvement in my burning feet or hands. About 6 months ago I raised the dose to 600 mg 1X per day but I don't feel that it helped with the burning. Abx has helped the burning quite a lot.

My naturopathic doctor was concerned with a dose of 600 because it can mobilize metals. It's fine for me now because I'm on a metal binder but be careful if you decide to take it at that dose.

Terry

Posts: 6286 | From Oregon | Registered: Jan 2006  |  IP: Logged | Report this post to a Moderator
BartonFink
LymeNet Contributor
Member # 10818

Icon 1 posted      Profile for BartonFink     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
My naturopathic doctor was concerned with a dose of 600 because it can mobilize metals. It's fine for me now because I'm on a metal binder but be careful if you decide to take it at that dose.

Terry [/QB]

Hi Terry

Yes I have heard about this warning about ALA too.

Just curious: which binder are you using? Any amalgams in the mouth?

--------------------
Please dont suggest "ask your LLMD" because we dont have them here in this country... [Frown] I just have to count on you fellow patients. [Smile]

Posts: 246 | From Finland | Registered: Dec 2006  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.